Voloridge Investment Management, LLC Repligen Corp Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $3.4 Million - $4.33 Million	-24,521 Reduced 78.21%	6,830 $1.09 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $2.64 Million - $3.44 Million	19,066 Added 155.2%	31,351 $4.43 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $875,271 - $1.12 Million	5,674 Added 85.83%	12,285 $2.07 Million
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $76,337 - $103,663	-470 Reduced 6.64%	6,611 $1.12 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.14 Million - $1.81 Million	7,081 New	7,081 $1.33 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $11.9 Million - $15.9 Million	-84,406 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $5.31 Million - $8.49 Million	32,918 Added 63.93%	84,406 $15.9 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $5.94 Million - $7.3 Million	-23,982 Reduced 31.78%	51,488 $13.6 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $4.61 Million - $7.68 Million	-23,691 Reduced 23.89%	75,470 $21.8 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $9.18 Million - $12.2 Million	55,370 Added 126.44%	99,161 $19.8 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $7.43 Million - $9.32 Million	41,197 Added 1588.16%	43,791 $8.51 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $1.84 Million - $2.56 Million	-12,402 Reduced 82.7%	2,594 $497,000
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $1.48 Million - $1.91 Million	12,068 Added 412.16%	14,996 $2.21 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $276,198 - $411,325	2,928 New	2,928 $362,000
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $495,826 - $636,941	-5,836 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $745,119 - $939,270	-10,091 Reduced 63.36%	5,836 $540,000
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $612,816 - $763,602	7,995 Added 100.79%	15,927 $1.22 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $190,079 - $301,426	-3,507 Reduced 30.66%	7,932 $682,000
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $306,985 - $389,862	6,208 Added 118.68%	11,439 $676,000
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $252,448 - $360,311	5,231 New	5,231 $276,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.09 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$923 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$729 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$235 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$205 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account